ESGCT 2026
13 hours ago
1 min read
We’re pleased to announce that Dr. Saqlain Suleman, Principal Scientific Officer at Testavec, will present a poster at the European Society of Gene and Cell Therapy (ESGCT) Congress:
“Understanding the host methylation response as a mechanism for genotoxicity”
📌 Poster: P0549
🧬 Category: Lentiviral Vectors | Integrative Vectors
Dr. Suleman will be joined by Hassan Abdulrazzak, PhD, Associate Scientist at Testavec. Both will be delighted to connect with attendees interested in gene therapy safety, vector genotoxicity and advancing safer therapeutic approaches.
If you’re attending ESGCT, please come and say hello. We look forward to the conversation.
Comments